Pfizer (United Kingdom)
In research, Pfizer (United Kingdom) stands highest in Medicine (#2,678 of 10,443 worldwide) and Health Sciences (#3,696 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #6,180 of 28,054 · #2,371 all time
- Rank in United Kingdom
- #238 of 1,094
- Research works
- 3.6k ▼ 4% vs 2013–17
- Citations
- 138k 38.4 per fractional work
- Top-10% rate
- 18.1% record average 16.5%
- Open access
- 30% world 28%
What is Pfizer (United Kingdom) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #2,678 of 10,443 | 19.2% | 156 | #1645 | |
| Health SciencesDomain | #3,696 of 11,982 | 18.9% | 167 | #2068 |
Each strip is that field’s whole ranked pool, with the notch where Pfizer (United Kingdom) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.0×. Every wedge is a field page.
- Immunology and Microbiology 7.0×
- Pharmacology, Toxicology and Pharmaceutics 6.4×
- Economics, Econometrics and Finance 3.4×
- Chemistry 3.0×
- Medicine 2.7×
- Biochemistry, Genetics and Molecular Biology 1.5×
- Health Professions 1.3×
- Mathematics 1.1×
- Veterinary 0.6×
- Neuroscience 0.6×
- Materials Science 0.5×
- Chemical Engineering 0.5×
- Decision Sciences 0.3×
- Nursing 0.3×
- Computer Science 0.2×
- Environmental Science 0.2×
- Engineering 0.2×
- Social Sciences 0.2×
- Dentistry 0.2×
- Agricultural and Biological Sciences 0.2×
- Psychology 0.1×
- Business, Management and Accounting 0.1×
- Arts and Humanities 0.1×
- Physics and Astronomy 0.1×
- Energy 0.0×
- Earth and Planetary Sciences 0.0×
Who are the top researchers at Pfizer (United Kingdom)?
Ranked on the composite score, Robert B. Stevenson, John C. Berridge and David C. Pryde lead among researchers whose main affiliation is Pfizer (United Kingdom).
- 1 Robert B. Stevenson United Kingdom · #83,436 worldwide 166 citations · 55 works
- 2 John C. Berridge United Kingdom · #204,673 worldwide 142 citations · 22 works
- 3 David C. Pryde United Kingdom · #277,781 worldwide 110 citations · 20 works
- 4 Byron Jones United Kingdom · #328,517 worldwide 34 citations · 31 works
- 5 Dennis A. Smith United Kingdom · #351,435 worldwide 99 citations · 30 works
- 6 Peter J. Dunn United Kingdom · #494,147 worldwide 136 citations · 73 works
- 7 John Steele United Kingdom · #526,011 worldwide 73 citations · 33 works
- 8 William Waddington United Kingdom · #587,697 worldwide 0 citations · 24 works
- 9 Michael Davey United Kingdom · #609,227 worldwide 54 citations · 23 works
- 10 R.L. Cornwell United Kingdom · #704,650 worldwide 18 citations · 15 works
Which keywords describe research at Pfizer (United Kingdom)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Quality of Life, Pathogenesis, Economic Evaluation, Cost-effectiveness Analysis, Health Utility Measures, Clinical Practice Guidelines and Vaccine.
- Minimal Residual Disease
- Clinical Characteristics
- Monoclonal Antibodies
- Medicinal Chemistry
- Mutation
- Antibiotic Resistance
- Chemotherapy
- Community-Acquired Pneumonia
- Respiratory Infections
- Respiratory Syncytial Virus
- ACE2 Receptor
- Disease Burden
- SARS-CoV-2
- Antimicrobial Resistance
- Vaccine
- Clinical Trials
- Cost-effectiveness Analysis
- Economic Evaluation
- Pandemic
- Quality of Life
- Epidemiology
- Inflammation
- Pathogenesis
- Clinical Practice Guidelines
- Health Utility Measures
- Public Health
- Vaccine Development
- Treatment
- Immune Response
- Viral Infections
- Human Metapneumovirus
- Immunity
- Vaccination
- Pneumococcal Conjugate Vaccine
- Autoantibodies
- Infectious Diseases
- Primary Care
- Thrombosis
- Pharmaceutical Industry
- Coronavirus
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology57▲ 4.8×71 topics
- Quality of Life17▲ 4.0×20 topics
- Inflammation15▲ 2.4×42 topics
- Pandemic12▲ 3.9×7 topics
- Pathogenesis12▲ 8.1×16 topics
- Economic Evaluation12▲ 34×2 topics
- Clinical Practice Guidelines12▲ 7.2×11 topics
- Cost-effectiveness Analysis12▲ 46×1 topic
- Health Utility Measures12▲ 46×1 topic
- Clinical Trials11▲ 5.4×13 topics
- Public Health11▲ 2.5×21 topics
- Vaccine11▲ 8.8×10 topics
- Vaccine Development10▲ 14×7 topics
- Antimicrobial Resistance10▲ 17×6 topics
- Treatment10▲ 2.7×29 topics
- SARS-CoV-210▲ 9.9×6 topics
- Immune Response10▲ 5.7×12 topics
- Disease Burden9▲ 42×2 topics
- Viral Infections9▲ 52×2 topics
- ACE2 Receptor9▲ 12×2 topics
- Human Metapneumovirus9▲ 63×1 topic
- Respiratory Syncytial Virus9▲ 63×1 topic
- Immunity8▲ 6.4×9 topics
- Respiratory Infections7▲ 21×2 topics
- Vaccination7▲ 33×2 topics
- Community-Acquired Pneumonia7▲ 70×1 topic
- Pneumococcal Conjugate Vaccine7▲ 70×1 topic
- Chemotherapy7▲ 3.3×18 topics
- Autoantibodies6▲ 9.2×6 topics
- Antibiotic Resistance6▲ 5.6×5 topics
- Infectious Diseases6▲ 6.3×5 topics
- Mutation6▲ 11×4 topics
- Primary Care6▲ 5.0×11 topics
- Medicinal Chemistry6▲ 6.6×7 topics
- Thrombosis5▲ 6.5×6 topics
- Monoclonal Antibodies5▲ 20×3 topics
- Pharmaceutical Industry5▲ 45×2 topics
- Clinical Characteristics5▲ 13×2 topics
- Coronavirus5▲ 7.4×3 topics
- Minimal Residual Disease5▲ 22×2 topics
Which research topics does Pfizer (United Kingdom) publish most on?
By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Respiratory viral infections research, Pneumonia and Respiratory Infections and COVID-19 Clinical Research Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 12 works
- 2 Respiratory viral infections research Epidemiology 9 works
- 3 Pneumonia and Respiratory Infections Epidemiology 7 works
- 4 COVID-19 Clinical Research Studies Infectious Diseases 4 works
- 5 Pharmaceutical Economics and Policy Economics and Econometrics 4 works
- 6 SARS-CoV-2 and COVID-19 Research Infectious Diseases 4 works
- 7 Rheumatoid Arthritis Research and Therapies Rheumatology 4 works
- 8 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 4 works
- 9 Vaccine Coverage and Hesitancy Health 4 works
- 10 Dermatology and Skin Diseases Dermatology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pfizer (United Kingdom)'s research output changed?
Output in 2018–2022 was 4% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.